Related Experiment Video
Updated: Jun 12, 2026
12:40
Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
Published on: December 7, 2012
Bottlenecks of blood processing in Uganda.
I Kajja1, D Kyeyune, G S Bimenya
1Department of Orthopedics, Makerere University College of Health Sciences, Kampala, Uganda. kajja133@gmail.com
Transfusion Medicine (Oxford, England)
|June 11, 2010
Summary
Delays in Uganda blood banks, caused by understaffing and outdated methods, prevent blood from reaching hospitals. Improving staffing and funding for Uganda Blood Transfusion Services is crucial to resolve these critical blood supply chain issues.
Area of Science:
- Public Health
- Health Systems Research
- Blood Transfusion Services
Background:
- Effective blood banks are essential for timely, safe blood component supply to hospitals.
- Poorly managed blood bank systems result in perceived shortages and increased wastage due to expiry.
Purpose of the Study:
- To pinpoint the locations and reasons for delays within Uganda's blood banks.
- To analyze the blood processing chain and identify bottlenecks.
Main Methods:
- Reviewed 4126 units of whole blood records from March to June 2009.
- Conducted staff interviews in two blood banks to determine causes of process delays.
Main Results:
- Average time from blood collection to release was 15.4 days.
- The longest delay occurred between matrix generation and grouping (median 8 days).
- Blood expiry led to the highest discard rate (0.17%); understaffing contributed to process flaws.
Conclusions:
- Significant blood wastage occurs due to processing delays between collection and dispatch.
- Inadequate staffing, materials, outdated methods, and poor environment cause these delays.
- Increasing staff and financial resources for Uganda Blood Transfusion Services can improve the situation.
Related Concept Videos
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:29Downstream Processing
Downstream processing begins once fermentation is complete and involves a series of steps to recover and purify products such as acids, vitamins, antibiotics, or proteins.Cell HarvestingFor example, for intracellular protein-based products, the first step is harvesting the cells. This is typically achieved using centrifugation or filtration to separate the cells from the liquid phase.Cell Disruption for Intracellular ProductsIf the target product is intracellular, the harvested cells must be...